ImageneBio Inc

IMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.78

-$0.03 (-0.62%)

Sep 22, 2026, 10:56 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.62%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $53.86M

1D Range

4.77 4.86

52W Range

3.94 9.10

Valuation (TTM)

PE -0.92

PB 0.38

EV/EBITDA 1.51

Valuation (NTM)

Forward PE N/A

Forward PEG -0.12

Price Target $1.33

Cash Flow

FCF Yield -135.3%

SBC Adj. FCF Yield -138.6%

SBC Impact -2.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -104.6% | -74.5%

Dil EPS 3Y | 5Y -78.2% | -33.0%

FCF 3Y | 5Y -0.4% | 6.4%

Returns

ROA -34.5%

ROE -39.0%

ROIC -39.8%

Financial Health

Net Cash

$136.15M

Current Ratio 21.47

Interest Coverage -614.18

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, ...

Sector Healthcare

Industry Biotechnology

Employees 18

IPO Date Feb 26, 1998

Website www.inmagenebio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Sell

Price Target

$1.33

Downside

-72.18%

Buy (0)

Hold (0)

Sell (1)

Analyst Details ➞